List of Tables
Table 1. Latent Tuberculosis Infection Screening Test Market Trends
Table 2. Latent Tuberculosis Infection Screening Test Market Drivers & Opportunity
Table 3. Latent Tuberculosis Infection Screening Test Market Challenges
Table 4. Latent Tuberculosis Infection Screening Test Market Restraints
Table 5. Global Latent Tuberculosis Infection Screening Test Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Latent Tuberculosis Infection Screening Test Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Latent Tuberculosis Infection Screening Test Product Type
Table 9. Key Companies Time to Begin Mass Production of Latent Tuberculosis Infection Screening Test
Table 10. Global Latent Tuberculosis Infection Screening Test Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection Screening Test as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Latent Tuberculosis Infection Screening Test Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Latent Tuberculosis Infection Screening Test Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Latent Tuberculosis Infection Screening Test Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Latent Tuberculosis Infection Screening Test Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Latent Tuberculosis Infection Screening Test Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Latent Tuberculosis Infection Screening Test Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Latent Tuberculosis Infection Screening Test Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Latent Tuberculosis Infection Screening Test Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Latent Tuberculosis Infection Screening Test Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Latent Tuberculosis Infection Screening Test Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Latent Tuberculosis Infection Screening Test Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Latent Tuberculosis Infection Screening Test Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Latent Tuberculosis Infection Screening Test Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Latent Tuberculosis Infection Screening Test Sales Value by Region (2019-2024) & (%)
Table 27. Global Latent Tuberculosis Infection Screening Test Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Latent Tuberculosis Infection Screening Test Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Latent Tuberculosis Infection Screening Test Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Latent Tuberculosis Infection Screening Test Sales Value, (2025-2030) & (US$ Million)
Table 31. Qiagen Basic Information List
Table 32. Qiagen Description and Business Overview
Table 33. Qiagen Latent Tuberculosis Infection Screening Test Products, Services and Solutions
Table 34. Revenue (US$ Million) in Latent Tuberculosis Infection Screening Test Business of Qiagen (2019-2024)
Table 35. Qiagen Recent Developments
Table 36. Oxford Immunotec Basic Information List
Table 37. Oxford Immunotec Description and Business Overview
Table 38. Oxford Immunotec Latent Tuberculosis Infection Screening Test Products, Services and Solutions
Table 39. Revenue (US$ Million) in Latent Tuberculosis Infection Screening Test Business of Oxford Immunotec (2019-2024)
Table 40. Oxford Immunotec Recent Developments
Table 41. Bio-Rad Laboratories Basic Information List
Table 42. Bio-Rad Laboratories Description and Business Overview
Table 43. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Products, Services and Solutions
Table 44. Revenue (US$ Million) in Latent Tuberculosis Infection Screening Test Business of Bio-Rad Laboratories (2019-2024)
Table 45. Bio-Rad Laboratories Recent Developments
Table 46. Thermo Fisher Scientific Basic Information List
Table 47. Thermo Fisher Scientific Description and Business Overview
Table 48. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Products, Services and Solutions
Table 49. Revenue (US$ Million) in Latent Tuberculosis Infection Screening Test Business of Thermo Fisher Scientific (2019-2024)
Table 50. Thermo Fisher Scientific Recent Developments
Table 51. Sanofi Basic Information List
Table 52. Sanofi Description and Business Overview
Table 53. Sanofi Latent Tuberculosis Infection Screening Test Products, Services and Solutions
Table 54. Revenue (US$ Million) in Latent Tuberculosis Infection Screening Test Business of Sanofi (2019-2024)
Table 55. Sanofi Recent Developments
Table 56. Par Sterile Basic Information List
Table 57. Par Sterile Description and Business Overview
Table 58. Par Sterile Latent Tuberculosis Infection Screening Test Products, Services and Solutions
Table 59. Revenue (US$ Million) in Latent Tuberculosis Infection Screening Test Business of Par Sterile (2019-2024)
Table 60. Par Sterile Recent Developments
Table 61. Key Raw Materials Lists
Table 62. Raw Materials Key Suppliers Lists
Table 63. Latent Tuberculosis Infection Screening Test Downstream Customers
Table 64. Latent Tuberculosis Infection Screening Test Distributors List
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
Table 68. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Latent Tuberculosis Infection Screening Test Product Picture
Figure 2. Global Latent Tuberculosis Infection Screening Test Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Latent Tuberculosis Infection Screening Test Sales Value (2019-2030) & (US$ Million)
Figure 4. Latent Tuberculosis Infection Screening Test Report Years Considered
Figure 5. Global Latent Tuberculosis Infection Screening Test Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Latent Tuberculosis Infection Screening Test Revenue in 2023
Figure 7. Latent Tuberculosis Infection Screening Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Tuberculin Skin Test (TST) Picture
Figure 9. Interferon Gamma Released Assay (IGRA) Picture
Figure 10. Global Latent Tuberculosis Infection Screening Test Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Latent Tuberculosis Infection Screening Test Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Diagnostic Laboratories
Figure 14. Product Picture of Others
Figure 15. Global Latent Tuberculosis Infection Screening Test Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Latent Tuberculosis Infection Screening Test Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Latent Tuberculosis Infection Screening Test Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Latent Tuberculosis Infection Screening Test Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Latent Tuberculosis Infection Screening Test Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Latent Tuberculosis Infection Screening Test Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Latent Tuberculosis Infection Screening Test Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Latent Tuberculosis Infection Screening Test Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Latent Tuberculosis Infection Screening Test Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Latent Tuberculosis Infection Screening Test Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Latent Tuberculosis Infection Screening Test Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Latent Tuberculosis Infection Screening Test Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Latent Tuberculosis Infection Screening Test Sales Value (%), (2019-2030)
Figure 28. United States Latent Tuberculosis Infection Screening Test Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Latent Tuberculosis Infection Screening Test Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Latent Tuberculosis Infection Screening Test Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Latent Tuberculosis Infection Screening Test Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Latent Tuberculosis Infection Screening Test Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Latent Tuberculosis Infection Screening Test Sales Value by Application (%), 2023 VS 2030
Figure 34. China Latent Tuberculosis Infection Screening Test Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Latent Tuberculosis Infection Screening Test Sales Value by Type (%), 2023 VS 2030
Figure 36. China Latent Tuberculosis Infection Screening Test Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Latent Tuberculosis Infection Screening Test Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Latent Tuberculosis Infection Screening Test Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Latent Tuberculosis Infection Screening Test Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Latent Tuberculosis Infection Screening Test Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Latent Tuberculosis Infection Screening Test Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Latent Tuberculosis Infection Screening Test Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Latent Tuberculosis Infection Screening Test Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Latent Tuberculosis Infection Screening Test Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Latent Tuberculosis Infection Screening Test Sales Value by Application (%), 2023 VS 2030
Figure 46. India Latent Tuberculosis Infection Screening Test Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Latent Tuberculosis Infection Screening Test Sales Value by Type (%), 2023 VS 2030
Figure 48. India Latent Tuberculosis Infection Screening Test Sales Value by Application (%), 2023 VS 2030
Figure 49. Latent Tuberculosis Infection Screening Test Industrial Chain
Figure 50. Latent Tuberculosis Infection Screening Test Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
